Regionalt Cancercentrum Mellansverige

What Regionalt Cancercentrum Mellansverige does

Regionalt Cancercentrum Mellansverige (RCC Mellansverige) is one of six regional cancer centers in Sweden operating under the umbrella of Regionala cancercentrum i samverkan, a national collaboration mandated by the Swedish regions and national healthcare authority to coordinate, standardize, and improve cancer care quality, accessibility, and equity. The organization operates from Uppsala and serves as a knowledge and quality infrastructure layer for the Swedish cancer care system, targeting three primary constituencies: healthcare professionals and clinicians (who consume care programs, treatment guidelines, clinical study information, and quality data), cancer patients and relatives (who access care plans, cancer advice lines, and self-service information via 1177.se), and the six Swedish regional healthcare authorities (which rely on RCC for quality monitoring, outcome reporting, and care-pathway standardization).

The core technology stack is anchored by the INCA platform — a national IT platform that hosts 30+ cancer quality registries and clinical study infrastructure — and includes several interoperable digital products: Individuell patientöversikt (IPÖ) for visualizing individual patient cancer disease, care, and treatment on a timeline; Cancerstudier i Sverige, a national database of approximately 300 ongoing clinical cancer studies; Kunskapsbanken, a national knowledge bank of care programs and supporting documents; Standardiserade vårdförlopp (SVF) for standardized care pathways with defined lead times; the National Cancer Registry; and a national drug regimen library (Nationella regimbiblioteket). The organization's analytical output is substantial, with 351 published national and regional quality reports across multiple cancer types. Notable operational impact documented in 2024 includes a reduction in median surgical wait time for low-malign glioma from 34 to 22.5 days and a halving of time from surgery to oncology start for high-malign glioma patients.

RCC Mellansverige is structured as a public, non-commercial healthcare coordination body funded through Swedish regional and national healthcare financing via Sveriges Kommuner och Regioner (SKR); it does not operate a commercial revenue model and has no disclosed budget or revenue figures. Distribution is dual-channel: a national digital platform (cancercentrum.se and the INCA platform) combined with six regionally distributed offices that provide localized coordination. The organization's growth is institutionally driven by its mandated scope rather than market dynamics, and it functions as a permanent piece of Swedish public health infrastructure rather than a commercially scalable entity.

Name

Regionalt Cancercentrum Mellansverige

Legal name

Regionalt Cancercentrum Mellansverige

Website

https://cancercentrum.se

Company type

Public

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Regionalt Cancercentrum Mellansverige is one of six Swedish regional cancer centers coordinating cancer care quality, accessibility, and equity across Sweden. It operates the INCA platform, national quality registries, and digital tools including IPÖ and Cancerstudier i Sverige, serving healthcare professionals, patients, and regional authorities.

Ownership category

akta.pro rank

Product category

Cancer Care Coordination

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ)

Keywords

• Cancer care coordination
• Clinical quality registries
• Standardized care pathways
• Oncology knowledge support
• Clinical cancer studies database

Headquarters

HQ city

Uppsala

HQ country

Sweden

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Distribution channels3 records

Marketing channels4 records

Core offering

Regionalt Cancercentrum Mellansverige is one of six Regional Cancer Centers (RCC) in Sweden that coordinates cancer care improvement under the national collaboration "Regionala cancercentrum i samverkan." It provides standardized care pathways (SVF), national clinical guidelines, quality registries via the INCA platform, the Individuell patientöversikt (IPÖ) IT tool, a national clinical cancer studies database, and a knowledge bank (Kunskapsbanken) for healthcare professionals and patients.

Product overview

Regionala cancercentrum i samverkan är en nationell samverkan av sex regionala cancercentrum, inklusive Regionalt Cancercentrum Mellansverige, med uppdrag att öka kvaliteten i cancervården och göra den mer patientfokuserad, tillgänglig och jämlik. Organisationen erbjuder ett integrerat ekosystem av digitala verktyg och kunskapsstöd: Individuell patientöversikt (IPÖ) som ett IT-verktyg för visualisering av patientdata; Cancerstudier i Sverige som en nationell databas för kliniska studier; Kvalitetsregister via INCA-plattformen för uppföljning av vårdkvalitet; Kunskapsbanken med vårdprogram och stöddokument; samt Standardiserade vårdförlopp (SVF) för enhetliga vårdprocesser. Tillsammans bildar dessa produkter en komplett digital infrastruktur för svensk cancervård.

Differentiator

Problem solved

Functional benefit

Brands

• IPÖ (Individuell patientöversikt): IT tool for collecting and visualizing individual patient cancer information, treatment and care on a timeline
• Kvalitetsregister (Quality Registers)
• SVF (Standardiserade vårdförlopp)
• Nationella regimbiblioteket
• Cancerstudier i Sverige

Products and services

• Individuell patientöversikt (IPÖ) IT-verktyg som möjliggör insamling och visualisering av uppgifter om den enskilde patientens cancersjukdom, vård och behandling. Informationen visualiseras på en tidslinje i en översiktsvy som ger en sammanfattande bild av patientens sjukdomshistoria och nuläge. Aimed at healthcare professionals and patients.
• Cancerstudier i Sverige National database with current clinical cancer studies. Contains only studies with ongoing patient recruitment, accessible to anyone though primarily aimed at researchers and healthcare professionals.
• Kvalitetsregister (National Cancer Quality Registers) National quality registers that facilitate monitoring and evaluation of healthcare results and quality within the cancer field, containing individual-based data on diagnoses, treatments, and outcomes across all Swedish regions.
• INCA-plattformen IT platform that supports quality registries and clinical studies within cancer care in Sweden. Used by authorized healthcare professionals across all Swedish regions.
• Kunskapsbanken National knowledge bank with care programs, supporting documents and evidence-based information for cancer care, intended for healthcare professionals.
• Standardiserade vårdförlopp (SVF) Standardized care pathways designed to ensure efficient and equitable cancer care with defined lead times and processes across Swedish regions.
• Nationella vårdprogram Nationally produced care programs and supporting documents for diagnosis, treatment and rehabilitation within different cancer areas.
• Cancerregistret National cancer registry with information on all cancer diagnoses in Sweden for follow-up and research purposes.
• Min vårdplan Tool for patients to follow their individual care plan within cancer care.
• Regimbibliotek för cancerläkemedel National drug regimen library with information on drug regimens for cancer treatment, including dosing and side effects.

Quantifiable outcome

• Contact nurse access increased to 90-97% in Sydöstra region (2024)
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Norwegian Cancer Registry (Kreftregisteret): Norway's national cancer registry operates a near-identical model to INCA: compulsory registration, individual-level data on diagnosis and treatment, and national quality reporting. Directly comparable as a Nordic national cancer registry and quality-improvement body.
• Finnish Cancer Registry: Finland's national cancer registry maintains population-level cancer statistics and quality data across the country. Directly comparable to RCC's role in Sweden, with similar public-health mandate and Nordic healthcare context.
• Canadian Partnership Against Cancer: An independent, federally funded organization that coordinates cancer control across Canadian provinces. Highly comparable to RCC's national coordination role, including standardized care pathways, quality reporting, and pan-jurisdictional data initiatives.
• Danish Health Data Authority - Cancer Registries: Denmark operates national cancer registries and quality databases through the Danish Health Data Authority, providing individual-level cancer data across regions. Directly comparable to RCC's INCA-based registry and quality-monitoring role in a Nordic public healthcare system.

Broad incumbents

• NHS England Cancer Programme: National Health Service England's cancer programme coordinates cancer care standards, waiting-time targets, and quality reporting across the English NHS. Comparable in mandate to RCC's SVF and quality registry work, though embedded in a much larger healthcare system.
• National Cancer Institute (NCI): The U.S. National Cancer Institute is a much larger federal cancer research and coordination agency. While broader in mission (research funding, trials, surveillance), it is directly comparable as a national-level body that sets cancer standards, operates registries (SEER), and drives care quality improvement.
• Cancer Research UK: The UK's largest cancer charity funds research, influences policy, and provides national-level information and data infrastructure. Comparable to RCC in its role as a national coordinator of cancer knowledge, registries, and care standards, though it operates through a charity/funder model rather than government mandate.
• German Cancer Research Center (DKFZ): DKFZ is Germany's national biomedical research institute and a key node in its cancer infrastructure. Comparable to RCC in operating national cancer registries, coordinating research, and producing treatment guidelines, though on a much larger scale.

Regional players

• European Cancer Information System (ECIS): ECIS is the EU-level cancer information system operated by the European Commission, providing pan-European cancer incidence and survival data. Comparable to RCC's Cancerregistret as a multi-country cancer surveillance and benchmarking platform, with similar registry and reporting functions.

Emerging players

• Karolinska Institutet (Cancer Research): Sweden's premier medical university conducts major oncology research and is closely linked to RCC's work on care programs and clinical studies. Comparable as a national knowledge producer in cancer, though its primary function is research rather than care coordination.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/regionala-cancercentrum-i-samverkan

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regionalt Cancercentrum Mellansverige